Skip to main content
. 2022 Jul 7;23(14):7535. doi: 10.3390/ijms23147535

Figure 4.

Figure 4

(A). Structure of E3 ligase ligands pomalidomide and VHL ligand as well as the adamantyl derivative HyT group. (B). General structure of HDAC8 inhibitors. (C). Schematic representation of designed HDAC8 PROTACs.